BlackRock Investment Management, LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 38 filers reported holding PSYCHEMEDICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2016$22,000
+29.4%
8770.0%0.00%
Q3 2016$17,000
+41.7%
8770.0%0.00%
Q2 2016$12,000
-7.7%
877
-8.5%
0.00%
Q1 2016$13,000
+30.0%
9580.0%0.00%
Q4 2015$10,000
+11.1%
958
+9.6%
0.00%
Q3 2015$9,000
-30.8%
8740.0%0.00%
Q2 2015$13,000
-13.3%
874
-4.9%
0.00%
Q1 2015$15,000
+7.1%
9190.0%0.00%
Q4 2014$14,000
+7.7%
9190.0%0.00%
Q3 2014$13,0000.0%9190.0%0.00%
Q2 2014$13,0009190.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 370,231$6,142,0004.61%
KELLEHER FINANCIAL ADVISORS 136,338$2,261,0001.25%
NAPLES GLOBAL ADVISORS, LLC 67,972$1,128,0000.54%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 193,500$3,210,0000.40%
North Star Investment Management Corp. 112,700$1,870,0000.35%
RBF Capital, LLC 78,495$1,302,0000.26%
CARL DOMINO INC 20,086$333,0000.25%
Granite Investment Partners, LLC 88,246$1,464,0000.13%
Moors & Cabot, Inc. 34,474$573,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 292,947$4,860,0000.08%
View complete list of PSYCHEMEDICS CORP shareholders